Search research articles
Contact Us
Filters
Showing results (111-120 of 243) with videos related to
Page
of 25
Sort By:
Neuro-Oncology Advances
|
June 27, 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safety
Thomas Zeyen, Antonia Treiber, Matthias Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2012
Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide
Moritz Stuplich, Dariusch R Hadizadeh, Klaus Kuchelmeister, et al.
Neurosurgical Review
|
January 2, 2023
Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?
Felix Lehmann, Anna-Laura Potthoff, Valeri Borger, et al.
Journal of Cancer Research and Clinical Oncology
|
November 23, 2019
Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma
Katharina Seystahl, Bettina Hentschel, Sarah Loew, et al.
Neuro-Oncology Practice
|
July 19, 2021
Chemotherapy for adult patients with spinal cord gliomas
Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Frontiers in Oncology
|
November 15, 2021
Dosimetric Comparison of Upfront Boosting With Stereotactic Radiosurgery Versus Intraoperative Radiotherapy for Glioblastoma
Gustavo R Sarria, Zuzanna Smalec, Thomas Muedder, et al.
Journal of Neuro-Oncology
|
October 3, 2023
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial
Johannes Weller, Thomas Zeyen, Niklas Schäfer, et al.
Neurosurgical Review
|
June 29, 2023
Incurring detriments of unplanned readmission to the intensive care unit following surgery for brain metastasis
Justus August Schweppe, Anna-Laura Potthoff, Muriel Heimann, et al.
Cancers
|
October 14, 2022
Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC)
Inja Ilic, Anna-Laura Potthoff, Valeri Borger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2015
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET
Sied Kebir, Rolf Fimmers, Norbert Galldiks, et al.
Page
of 25
Search research articles
Search
Showing results (111-120 of 243) with videos related to
Sort By:
Page
of 25
Neuro-Oncology Advances
|
June 27, 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safety
Thomas Zeyen, Antonia Treiber, Matthias Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2012
Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide
Moritz Stuplich, Dariusch R Hadizadeh, Klaus Kuchelmeister, et al.
Neurosurgical Review
|
January 2, 2023
Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?
Felix Lehmann, Anna-Laura Potthoff, Valeri Borger, et al.
Journal of Cancer Research and Clinical Oncology
|
November 23, 2019
Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma
Katharina Seystahl, Bettina Hentschel, Sarah Loew, et al.
Neuro-Oncology Practice
|
July 19, 2021
Chemotherapy for adult patients with spinal cord gliomas
Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Frontiers in Oncology
|
November 15, 2021
Dosimetric Comparison of Upfront Boosting With Stereotactic Radiosurgery Versus Intraoperative Radiotherapy for Glioblastoma
Gustavo R Sarria, Zuzanna Smalec, Thomas Muedder, et al.
Journal of Neuro-Oncology
|
October 3, 2023
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial
Johannes Weller, Thomas Zeyen, Niklas Schäfer, et al.
Neurosurgical Review
|
June 29, 2023
Incurring detriments of unplanned readmission to the intensive care unit following surgery for brain metastasis
Justus August Schweppe, Anna-Laura Potthoff, Muriel Heimann, et al.
Cancers
|
October 14, 2022
Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC)
Inja Ilic, Anna-Laura Potthoff, Valeri Borger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2015
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET
Sied Kebir, Rolf Fimmers, Norbert Galldiks, et al.
Page
of 25